DiaMedica Therapeutics(DMAC)
MINNEAPOLIS, MN
BiotechnologyFocus: Biologics
DiaMedica Therapeutics is a life sciences company focused on Biologics.
NeurologyNephrologyMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
DM199
Pre-EclampsiaClinical Trials (1)
NCT06875141DM199 for Pregnancy Complications
N/APhase 1
Clinical Trials (1)
NCT03795389Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
Phase 1Recombinant human tissue kallikrein
StrokeClinical Trials (1)
NCT02868996An Open Label, Phase 1b, Ascending Dose Study of DM199
Phase 1DM199
Diabetes Type 2Clinical Trials (1)
NCT01845064A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients
Phase 1/2Recombinant human tissue kallikrein
Acute Ischemic StrokeClinical Trials (1)
NCT03290560Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
Phase 2DM199
Kidney DiseasesClinical Trials (1)
NCT04123613Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)
Phase 2Recombinant human tissue kallikrein
Acute StrokeClinical Trials (1)
NCT05065216Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 7 clinical trials
SEC Filings: 2 available